Which of the following is true about hemophilia A?
A) Today recombinant DNA technology is used to make clotting factors free from contamination of viruses to treat hemophilia patients.
B) Hemophilia A is less common than hemophilia B.
C) More females have hemophilia A than males.
D) Hemophilia A is associated with a lack of clotting-factor X.
E) Hemophilia A leads to muscle wasting.

Question

Quizplus · Accepted Answer

Recombinant DNA technology is currently used to produce clotting factors for treating hemophilia A patients, ensuring that the products are free from viral contamination. This has been a significant improvement in hemophilia A therapy, as it reduces the risks of blood-borne infections among patients. Hemophilia A is caused by a deficiency in clotting-factor VIII, not X. It is also more common in males than females, and it does not typically lead to muscle wasting.

Which of the Following Is True About Hemophilia A